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Mycoplasma pneumoniae (MP) is, considered to affect rarely children less than 5 yrts of age.
This study was performed to describe the epidemiology and the clinical features of MP lower
respiratory tract infection (LRTI) in children, presenting to a tertiary children hospital.
Eleven month-longitudinal study of LRTI due to MP, diagnosed by polymerase chain reaction
(PCR) on throat swab specimen, was performed.
Out of 866 children with LRTI admitted to the Gaslini Pediatric Institute in Genoa, 102 had
a positive PCR for MP. We found 39 preschool-aged children, 42 school-aged children and 21
young adolescent [6.20 (3.81) yrs old]. Interestingly, eight MPþ infants had <8 months of
age. The commonest presentations were cough and/or fever (76.5%). Tachypnoea, upper respi-
ratory tract involvement, diarrhoea and vomiting were more common in the <5 yr Gr as
compared to the other groups. Chest X-ray was found abnormal in 76 children: consolidations
were the commonest finding. Laboratory test showed that the preschool-aged children had
a higher number of lymphocytes (p< 0.0001) and monocytes (pZ 0.009). Thrombocytosis
was found in 35.7% of children and was more frequent in the preschool-aged children
(pZ 0.013).
MP infection is common in preschool-aged children, including young infants, and may have
different clinical presentation, as compared to older children.
ª 2008 Elsevier Ltd. All rights reserved.10 5636547; fax: þ39 010 383953.
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Mycoplasmas, the smallest known free-living forms, have
been associated with a variety of clinical manifestations,
including those involving the respiratory tract which are
related to Mycoplasma pneumoniae (M. pneumoniae).1,2
Indeed, M. pneumoniae is a significant cause of respiratory
tract infections in humans and an important pathogen in
acute respiratory illnesses in children and in adults,
accounting for as many as 20e40% of all cases of commu-
nity-acquired pneumonia.2e4
However, as direct invasion of the different tissues or,
indirectly, as a result of the host immune system reaction
to infection, M. pneumoniae can also cause extrapulmonary
disorders affecting the skin, the gastrointestinal tract, the
cardiovascular, musculoskeletal, nervous and renal sys-
tems.1e4
Current concepts recognize that community-acquired
epidemics due to M. pneumoniae infection affect mainly
school-aged children and young adults.2e5 The assumption
that M. pneumoniae disease is rare in preschool-aged
children may probably precluded most physicians from
considering it in the differential diagnosis in this age popu-
lation. However, in the last decades studies indicated that
M. pneumoniae infection may be frequent in children less
than 5 yrs old, and suggested differences in its clinical
presentation between younger and older patients.6e9
Evaluating paediatric patients with community-acquired
pneumonia in Finland, it was found that out of the children
with a confirmed diagnoses of M. pneumoniae infection,
21% were <5 yrs of age,6 while during an epidemic outbreak
of M. pneumoniae infection in Catalonia, rate in children
<5 yrs old was 18% versus 8.2% in those 5e14 yrs old.7 In
contrast, evaluating the prevalence of M. pneumoniae in
children in Turkey, detection of serum specific IgG was posi-
tive only in children >2 yrs old, with a sudden increase in
seropositivity at 7 yrs of age.8 Finally, the age group most
commonly affected by M. pneumoniae infection in children
presenting to a tertiary children’s hospital in Australia was
5e9 yrs, followed by children of 1e5 yrs old.9 Even though
the commonest presentation in this study population was
with cough and fever, coryza, diarrhoea, vomiting, tachyp-
noea and recession were significantly more common in chil-
dren less than 5 yrs than in children 5e15 yrs.9
Due to the non homogeneous and limited data in the
literature an 11-month-longitudinal study was performed to
evaluate the epidemiology, the clinical and roentgeno-
graphic features and the laboratory results of M. pneumo-
niae lower respiratory tract infection (LRTI) in children,
presenting to a tertiary children’s hospital, aimed to
evaluate possible age-related difference in the presenting
clinical features.
Materials and methods
Study population
Eight hundred and eighty-six consecutive children with
lower respiratory tract infection (LRTSI) admitted to the
Gaslini Institute in Genoa were evaluated prospectively
over a an 11-month period (October 1, 2005eAugust 31,2006). Children were eligible for enrolment if they had: (a)
clinical (fever, persistent cough, tachypnoea, chest retrac-
tions, or abnormal auscultatory findings) and/or radiologic
evidence of LRTI (presence of consolidation, interstitial
changes, pleural effusion or mediastinal lymphadenopathy)
and (b) positive PCR and elevated IgM at admission or at
follow-up or a fourfold increase in IgG.
For this research, fever was defined as a recorded
temperature 38.0 C on admission.
Children were excluded if they had severe concomitant
disease such as kidney or liver disease, neoplasms, primary
ciliary dyskinesia, cystic fibrosis, congenital or acquired
immunodeficiency or immunosuppression, due to systemic
disorders, or treatments, cardiovascular disease or malab-
sorption syndromes.
According to the clinical findings, children were diag-
nosed as: (a) acute bronchitis, with or without wheezing, if
they had cough and rhonchi, with a normal chest radio-
graph, when performed; (b) wheezy bronchitis if they had
cough, and/or dyspnoea with expiratory rales and/or
wheezes unrelated to any known specific sensitization,
with a normal chest radiograph or hyperinflation, when
performed; (c) pneumonia if they had diffuse or lobar
pulmonary infiltration evident on the chest radiograph; (d)
bronchiolitis when wheezing and/or dyspnoea and/or
tachypnoea, and roentgenographic evidence of hyperinfla-
tion of the lung with or without areas of collapse were
present.5,10,11
Patient evaluation
Demographic and clinical data were collected uniformly
from all children and laboratory specimens were obtained.
These included nasal and throat swab specimens and blood
samples cultured and processed in accordance with stan-
dard microbiological procedures for bacteria and the most
common respiratory viruses. Blood samples were evaluated
also for total cells and differential counts and serum level
of C-reactive protein (CRP). Chest X-ray were was per-
formed when clinically indicated. Diagnosis of M. pneumo-
niae infection was based on real-time PCR by targeting the
P1 cytoadhesin type 1 and 2 gene of the M. pneumoniae
genome using DNA extracted from oropharyngeal swabs.
The swabs, stored in 1 ml of sterile PBS, were centrifuged
at 14,000 rpm for 10 min and the pellets were resuspended
in 200 ml of PBS and processed to extract DNA with QIAamp
DNA Mini kit (QIAGESPAN S.p.A., Milano, Italy). The PCR
reaction was performed on samples and on positive and
negative controls as follows: the 72 bp fragment of the
target gene was amplified using Mycpn P1-F forward primer
(50-GCC GCA AAG ATG AAY GAC G-30) and Mycpn P1-F
reverse primer (50-TCC TTC CCC ATC TAA CAG TTC AG-30)
in combination with a TaqMan probe (50FAM-TTG ATG GTA
TTG TAC GCA CCC CAC TCG-30 TAMRA). Reaction was
carried out with the Rotor Gene 3000 (Corbett Research,
Diatech SRL, Italy) instrument. Each reaction mixture was
performed in 25 ml containing template DNA, 1 Platinum
Quantitative PCR SuperMix-UDG Master Mix (Invitrogen,
Milano, Italy), primers at 300 nM and probe at 200 nM.
PCR cycling conditions were 2 min at 50 C, 2 min at 95 C
and then 40 cycles of denaturation at 95 C for 20 s and
annealing/extension 58 C for 60 s.12e15 PCR results were
1764 A. Defilippi et al.available within 3 h. Acute IgM serology and/or elevated IgG
titers in serum were also evaluated using a commercial test
kit (Serion ELISA classic M. pneumoniae IgG/IgM, Institut Vir-
ion\SerionGmbH, Friedrich-Bergius-Ring 19 97076Wu¨rzburg,
Germany). IgM and IgG levels for M. pneumoniae were also
re-evaluated 3e4 toweeks later, in ‘‘convalescence phase’’,
in patients with IgM< 30 U/ml and IgG< 17 U/ml.
The Institutional Ethical Committee of the Gaslini
Institute approved the protocol. Signed informed parental
consent were obtained.
Data analysis
Descriptive statistics were performed and reported in terms
of absolute frequencies or percentages for qualitative data,
in terms of means or medians with standard deviations (SD)
or lower and upper quartiles in parenthesis for quantitative
data. Quantitative variables such as white blood cells,
platelet count and oxygen saturation less in room air
were dichotomized on the basis of the their ‘normal’ values
related to different ages. Comparison of quantitative vari-
ables among the three age groups of patients was made by
ANOVA or KruskaleWallis test when appropriate. Compar-
ison of frequency distribution was made by means of the
Chi-Square test, and the Fisher’s exact test was used in
case of at least one expected frequency less than 5. All
tests were two-tailed. Data were analysed using STATA
version 7.0. A difference of P< 0.05 was considered to be
statistically significant.
Results
Patients
Out of the eight hundred and eighty-six children admitted
for an acute respiratory disease, 102 (12%) had a positive
PCR for M. pneumoniae and, of those, 63 (62.2%) had also
antigen-specific IgM and/or antigen-specific IgG levels in
the serum. The male to female ratio of the patients with
M. pneumoniae infection (PCR positive) was 1.17 and the
mean age was 6.20 (3.81) yrs, ranging from 1 month to
13.5 yrs. Subdividing the M. pneumoniae positive children
into 3 age groups, we found 21 (20.6%) young adolescent
(i.e. 10e14 yrs old), 42 (41.2%) school-aged children
(i.e. >5e<10 yr) and 39 (38.2%) preschool-aged children
(i.e. <5 yr). In this latter group, 22 (21.57%) children
were less than 24 months (Fig. 1). The mean hospital stay
was 4.82 (2.68) while the treatment duration with macro-
lides (chlarytromicin) was 11 2 days.
Infection associated with M. pneumoniae occurred
throughout the year, with 9 cases seen in most of the
months. A peak was observed in June with a total of 23
(22.5%) cases seen during that period of the year (Fig. 2).
Clinical presentation
Respiratory manifestations
The predominant onset symptoms were fever, [75 (73.5%)]
and cough [43 (42.1%)]. Usually children reported the
presence of persistent cough and fever, insensitive to
beta-lactam antibiotics treatment. Cough was mostfrequently described as moist, although a dry, non-produc-
tive cough was also described. In some patients, symptoms
began abruptly with respiratory distress, with an oxygen
saturation less than 95% in room air, detected in 36 (35.3%)
children; none of these patients required assisted ventila-
tion. Dyspnoea was detected in 28 children (27.5%). On
physical examination children were found to have mild-to-
moderate expiratory wheeze and inspiratory and expiratory
crackles.
Although the respiratory system was always predomi-
nantly involved, twenty patients also had significant gastro-
enterologic manifestations, such as vomiting [15 (14.7%)]
and diarrhoea [5 (4.9%)]. Two patients had a history of
diffuse macular rash during illness involving the trunk and
limbs and 2 patients of arthralgia while none presented
haemolytic anaemia or symptoms suggesting nervous
system involvement. Comparison among the three age
groups, showed that dyspnoea, upper respiratory tract
involvement, diarrhoea and vomiting were more common
in the preschool-aged group (38.46%) as compared to the
older groups (14.29% in school-aged children and 28.57% in
young adolescents) (pZ 0.047). Similarly, we also observed
that dyspnoea was more frequently diagnosed in preschool-
aged children than in older children (Table 1). Among the
102 patients evaluated, 6 (5.89%) had a previous diagnosis
of asthma and 42 (41.18%) had previous history of upper
and/or lower respiratory tract infections.
Investigations
A chest X-ray was performed in 81 of the 102 children.
Seventy-six roentgenograms (93.8%) were reported as
abnormal. Consolidation was the commonest finding, in 62
(76.5%) of the radiological abnormalities recorded, more
often unilateral (53.09%) than bilateral (23.46%). Intersti-
tial changes were reported in 14 patients (17.28%), and
pleural effusion in 6 (7.4%). Mediastinal lymphadenopathy
was never detected.
On the basis of both clinical and roentgenographic
findings, a diagnosis of pneumonia with or without pleural
effusion was done in 77 children, acute bronchitis in four,
wheezy bronchitis in 18 and bronchiolitis in three.
Interstitial changes were more frequently reported in
preschool-aged group than in school-aged or young adoles-
cent groups (p< 0.0001, Table 1) whereas consolidations
were more frequently reported in the 5e<10 yrs and
10 yrs groups than in <5 yrs group (pZ 0.004) (Table 1).
A full blood count was available in all patients. Total
WBC count varied from 3.33 103 to 26.56 103 cells/mm3
(mean 11.22 103 cells/mm3). Normal leukocyte total and
differential count, was found in 82 patients (81%). Twenty
children (19%) had leukocytosis. Thrombocytosis, defined
as a platelet count more than 400 109/L, was documented
in 33 (32.35%) patients. None of the patients evaluated had
haemoglobin of less than 8 g/L and/or haemolytic anaemia
secondary to M. pneumoniae infection.
Comparison of laboratory tests results among different
age groups (Table 2) showed that children in the<5 yrs group
had a higher number of lymphocytes (p< 0.0001) and mono-
cytes (pZ 0.009). Also thrombocytosis was more frequent in
preschool-aged (pZ 0.013). Serum C-reactive protein was
also measured in all patients: 77% had an increased level of
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Figure 1 Number of children admitted for an acute lower respiratory tract disease with positive polymerase chain reaction (PCR)
for M. pneumoniae in the different age groups. The number of children evaluated is expressed on the ordinate and the different
age groups on the abscissa.
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22.21 mg/dl, median: 1.55 mg/dl). IgG and IgM antibodies
against M. pneumoniae were quantitatively detected in 83
serum samples by using the ELISA. test were analyzed
Elevated serum levels of M. pneumoniae-specific IgM and/
or IgG, confirming a diagnosis of M. pneumoniae infection,
were detected in 38 (45.8%) on admission (Table 3). In
patients with negative sierology, a ‘‘convalescent’’ sample
was obtained and showed in all patients an elevation of M.
pneumoniae-specific IgM and/or IgG levels (>30 U/ml and
>17 U/ml, respectively) consistent with a recent M. pneu-
moniae infection.
Co-infections with RSV occurred in 4 children younger
than 2 yrs.N
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Figure 2 Number of children with positive polymerase chain re
respiratory tract disease in the period October 2005-August 2006. T
and the different months when admission was performed on the aCharacteristics of M. pneumoniae infection in
patients less than 1 yr of age
In the 2 yrs group, 8 infants had 8 months of age, (two 1
month old, one 4 months old, two 5, one 6 and two 8
months old, respectively) and, in addition to a positive
PCR for M. pneumoniae, three had also detectable
antigen-specific IgM and IgG in serum. Transcutaneous
oxygen saturation in room air was <95% only in two patients
and, in addition to respiratory symptoms, three presented
vomiting. Chest X-ray was reported as abnormal in all but
one infant (6 had interstitial changes and two parenchymal
consolidations) while co-infections with RSV occurred in
three cases (Table 4).2006
h Apr May June July August
action (PCR) for M. pneumoniae, admitted for an acute lower
he number of children evaluated is expressed on the ordinate
bscissa.
Table 1 Comparison of clinical features of Mycoplasma pneumoniae infection among different age groups
<5 yrs (No. 39) 5e<10 yrs (No. 42) 10 yrs (No. 21) p-Value
Fever [No. (%)] 27 (69.23%) 34 (80.95%) 14 (66.67%) 0.36
Wheezing [No. (%)] 13 (33.33%) 12 (28.57%) 11 (52.38%) 0.17
Cough [No. (%)] 19 (48.72%) 31 (73.81%) 12 (57.14%) 0.06
Dyspnoea [No. (%)] 18 (46.15%) 6 (14.28%) 4 (19.05%) 0.004
Diarrhoea [No. (%)] 3 (7.69%) 2 (4.76%) 0 (0) 0.53a
Coriza [No. (%)] 9 (23.08%) 5 (11.90%) 1 (4.76%) 0.16a
Vomiting [No. (%)] 8 (20.51%) 5 (11.90%) 2 (9.52%) 0.51a
SaO2< 97% [No. (%)] 15 (38.46%) 15 (35.71%) 6 (28.57%) 0.60
Crackles [No. (%)] 12 (30.77%) 20 (47.62%) 8 (38.10%) 0.30
Consolidations [No. (%)] 14 (53.85%) 34 (89.47%) 14 (82.35%) 0.004a
Monolateral consolidation [No. (%)] 10 (71.43%) 24 (70.59%) 9 (64.29%) 0.89a
Bilateral consolidation [No. (%)] 4 (28.57%) 10 (29.41%) 5 (35.71%) e
Interstitial changes [No. (%)] 11 (42.31%) 2 (5.26%) 1 (5.88%) <0.0001a
p-Values in the table refer to Chi-square test, unless otherwise specificied.
a Fisher’s Exact test.
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Evaluating children admitted for lower respiratory tract
infection (LRTI) over an 11-month period, we found that
approximately 12% had a positive PCR for M. pneumoniae
and of these, 39 were less than 5 yrs old, including 8 infants
younger than 8 months of age. In all children with M. pneu-
moniae infection the commonest symptoms were cough and
fever, while chest X-ray demonstrated predominantly
consolidations (76% of the radiological abnormalities
recorded), interstitial changes, and pleural effusions being
reported, respectively, in 17 and 7%. Differences in theTable 2 Comparison of laboratory values of Mycoplasma pneum
<5 yrs (No. 39) 5
White blood cells (cells/mm3) 12.88 (6.12) 1
Monocyte number (cells/mm3)
[mean (SD)]
0.80 (0.46)
Monocytes percentage [median
(lowereupper quartiles)]
6.11 (4.70e8.75)
Lymphocyte number (cells/mm3)
[mean (SD)]
4.22 (3.25)
Lymphocyte percentage [median
(lowereupper quartiles)]
35.71 (20.30e43.44) 1
Neutrophil number (cells/mm3)
[mean (SD)]
7.11 (4.71)
Neutrophil percentage [median
(lowereupper quartiles)]
49.91 (41.50e69.91) 6
Eosinophil number (cells/mm3)
[mean (SD)]
0.30 (0.34)
Eosinophil percentage [median
(lowereupper quartiles)]
1.31 (0.76e2.98)
Platelet number (cells/mm3)
[mean (SD)]
409.8 (150.6) 3
Serum C-reactive protein (mg/dl)
[median (lowereupper quartiles)]
0.89 (0.46e2.24)
{p< 0.05, comparison between age group 1 and age group 3; {{
{{{p< 0.001, comparison between age group 1 and age group 3;
**p< 0.01, comparison between age group 1 and age group 2; and ***clinical presentation of M. pneumoniae infection were
detected among younger and older patients. In children
less than 5 yrs old tachypnoea, upper respiratory tract
involvement, diarrhoea and vomiting were more common
(pZ 0.047), interstitial changes on chest X-rays were
more frequently reported and laboratory test showed
higher number of lymphocytes and monocytes. Thrombocy-
tosis and co-infections with RSV were also more common in
the younger than in the older patients.
M. pneumoniae infections have been traditionally
thought to occur in school-aged children, although recent
studies indicated that it may be less rare than believed inoniae infection among different age groups
e<10 yrs (No. 42) ‡10 yrs (No. 21) p-Value
0.59 (4.81) 9.60 (4.15) 0.08
0.65 (0.83)* 0.48 (0.17){ 0.009
4.65 (3.49e6.53) 5.54 (3.74e7.59) 0.17
2.26 (1.20)*** 1.72 (0.58){{{ <0.0001
9.65 (16.40e30.05)** 18.64 (13.10e25.98){{ <0.001
7.36 (4.19) 7.07 (4.09) 0.96
9.37 (57.75e74.93)** 71.27 (62.75e80.25){{ <0.001
0.23 (0.21) 0.21 (0.18) 0.35
1.91 (0.76e3.64) 1.70 (0.83e3.78) 0.84
34.7 (114.1)* 316.6 (90.84){ 0.009
1.64 (1.24e3.40) 2.09 (0.83e3.56) 0.69
p< 0.01, comparison between age group 1 and age group 3;
*p< 0.05, comparison between age group 1 and age group 2;
p< 0.001, comparison between age group 1 and age group 2.
Table 3 Age-dependent distribution of Mycoplasma pneu-
moniae infection on the basis of serological and PCR findings
at admission
<5 yrs
(No. 39)
5e<10 yrs
(No. 42)
10 yrs
(No. 21)
Antigen-specific
IgM [No. (%)]
9 (23.08) 21 (50.00) 6 (28.57)
Antigen-specific
IgG [No. (%)]
5 (12.8) 13 (30.95) 4 (19.05)
PCR [No. (%)] 39 (100.00) 42 (100.00) 21 (100.00)
Mycoplasma pneumoniae infection in childhood 1767children less than 5 yrs old.6,8,9,13 Indeed, reports from
different countries indicate that the incidence of M. pneu-
moniae is highest, in school-aged children, but also in chil-
dren 1e5 yrs of age, but with infants less than 1 yr old were
rarely affected.6,8,9,13,14 The results here reported are only
partially in agreement with the other studies since out of
the 102 children with M. pneumoniae infection, 42 were
between 5 and 10 yrs of age and 21 between 10 and
14 yrs of age, but 39 were less than 5 yrs old, including 8
young infants.
Indeed, in the study performed in Finland, but only on
patients with community-acquired pneumonia, only 21% of
the children with M. pneumoniae infection were <5 yrs of
age, a percentage similar to the 18% reported during the
epidemic outbreak in Catalonia,7 while in the Australian
study, out of the children presenting to a tertiary children’s
hospital with M. pneumoniae infection, 39% were less than
5 yrs old.9
The relatively low incidence in adolescents, found in the
present but also in other reports,9 may be probably
explained by the observation that among persons who
have had M. pneumoniae infection, rates of subsequent
relapse are low because immunity appears to increase
progressively with age.14
Unlike endemic disease, which may not demonstrate
marked seasonal occurrence, it is generally though that
outbreaks of M. pneumoniae infection in countries withTable 4 Clinical features of Mycoplasma pneumoniae infection
Pt ID Age
(yrs)
Sex Clinical presentation Chest
auscultation
SaO2 (%)
1 0.30 F Coryza, cough and
vomiting
Bronchial
breathing
99
2 0.44 M Fever Crackles and
wheeze
100
3 0.12 F Vomiting Crackles 98
4 0.12 M Cough Crackles 100
5 0.54 F Cough Tachydyspnoea Wheeze 99
6 0.42 F Tachydyspnoea Wheeze 94
7 0.69 F Cough Wheeze 93
8 0.64 M Fever Bronchial
breathing
97temperate climates, such as Italy, tend to occur in the
summer or early fall, when the occurrence of other respira-
tory pathogens is generally lower.15 Although we have
observed a peak incidence in June, with a total of 23 cases
out of a total of 102, M. pneumoniae infection occurred
throughout all the period evaluated, with 12 and 99 cases,
respectively, in December and January.
To select children with M. pneumoniae infection at
enrolment, positivity of PCR on throat swab specimen, an
approach thought to be highly sensitive and specific was
considered.16,17 Indeed, lack of antibody response to
M. pneumoniae has been noted in both paediatric and adult
populations with culture- and/or PCR-positive community-
acquired pneumonia18 and nonspecific stimulus by lipids
of other organisms may lead to production of crossreacting
antibodies.14 The diagnosis of M. pneumoniae infection was
then confirmed by the presence of elevated serum levels of
M. pneumoniae-specific IgM and/or IgG, in the acute phase
or their increase in the convalescent phase.
The clinical presentation observed in our patient popula-
tion did not differ greatly from that described in other
studies,1,2,7 fever and cough being the most common symp-
toms. Despite the hospital-based nature of our study, the
rate of acute dyspnoeaandwheezingwas lower than recently
reported in a similar series.9 Consistentwith the results of this
latter study, we found a significant difference in clinical
features between the younger and older children with M.
pneumoniae infection, dyspnoea, upper respiratory tract
involvement, diarrhoea and vomiting being more common in
the less than 5 yrs old group than in the other two groups.
A high proportion of children had a chest roentgeno-
grams reported as abnormal, but without pathognomonic
features: segmental or patchy consolidation was common in
the whole population studied, as in other series,6,19 while
interstitial changes were more often reported in the youn-
gest group. Pleural effusion was a relatively rare finding
and hilar or mediastinal lymphadenopathy was never
detected.6,19,20 The observation that the present study
was performed on children presenting and admitted to
a tertiary children’s hospital may also explain the highin children less than 8 months of age
Temperature
(C)
Chest X-ray Co-infection
36.8 Bilateral consolidation None
38.5 Interstitial changes or
interstitial infiltrates
RSV
36.8 Interstitial changes or
interstitial infiltrates
None
37.6 Interstitial changes or
interstitial infiltrates
None
36.5 Interstitial changes or
interstitial infiltrates
None
36.3 Normal RSV
36.7 Interstitial changes or
interstitial infiltrates
None
39.2 Unilateral consolidation RSV
1768 A. Defilippi et al.proportion of cases with clinical and roentgenographic find-
ings consistent with M. pneumoniae-induced pneumonia, as
compared with milder manifestations.
Finally, preschool-aged children had a higher number of
lymphocytes, monocytes and platelets. It is interesting to
note that thrombocytosis has been reported only twice in
children9 and in elderly adults.21
In conclusion, consistent with other studies, these
results emphasize the concept that M. pneumoniae should
be kept in mind as a cause not only of community-acquired
pneumonia, but also of milder respiratory infections in chil-
dren less than 5 yrs old. Indeed, M. pneumoniae may cause
not only pneumonia but also other respiratory syndromes
such as bronchitis, bronchiolitis, mimicking viral respiratory
infections.
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